New research from the American Heart Association and Cedars-Sinai Medical Center links moderate daily coffee consumption to significant cardiovascular and liver health benefits.
The American Heart Association statement, published in Circulation on July 20, 2026, notes that most adults can safely consume up to 400 mg of caffeine daily—about five eight-ounce cups of coffee.
Researchers observed that moderate coffee intake is associated with a lower risk of heart failure, heart disease, stroke, and type 2 diabetes.
They emphasized that filtering coffee with paper traps diterpenes like cafestol, preventing increases in bad LDL cholesterol.
Cedars-Sinai Study Shows Liver Benefits
A separate study from Cedars-Sinai, published in Clinical Gastroenterology and Hepatology on July 25, 2026, tracked 354,957 UK Biobank participants over 13 years.
The research demonstrated that consuming five or more cups of coffee daily lowered the risk of cirrhosis by 32%, liver cancer by 47%, and liver-related death by 42% compared to non-drinkers.
MRI scans revealed lower levels of liver fat, scarring, and inflammation among regular coffee drinkers.
Health experts evaluated the findings and addressed the underlying biological mechanisms in their official statements.
“We have made tremendous progress in understanding the health effects of caffeine, but there is still a lot to learn,” said Frank Hu, Fredrick J.
Stare Professor of Nutrition and Epidemiology and chair of the Department of Nutrition at Harvard T. H. Chan School of Public Health.
Medical researchers noted that observational data across hundreds of thousands of individuals provides strong biological support for coffee’s protective effects, though lifestyle factors also play a key role.
“Previous studies suggested that coffee might benefit the liver, but most were smaller or looked at only one piece of the puzzle,” said Hyunseok Kim, MD, MPH, PhD, assistant professor of Medicine at Cedars-Sinai and corresponding author of the study.
“We followed hundreds of thousands of people for more than a decade and looked at their health outcomes along with liver MRI scans and blood protein analyses.
Together, those findings help explain the biological mechanisms behind coffee’s association with better liver health.”
Clinical leaders emphasized that while coffee consumption is beneficial, individuals should maintain established health practices and consult doctors regarding high caffeine intake if they have pre-existing conditions.
“Our findings support moderate coffee consumption for people who already enjoy and tolerate it well,” said Ju Dong Yang, MD, medical director of the Liver Cancer Program at Cedars-Sinai.
“However, we would not recommend that someone begin drinking coffee solely for liver protection based on this study alone.
Prevention should continue to focus on maintaining a healthy weight, limiting alcohol, exercising regularly, and managing blood sugar, blood pressure and cholesterol.”
Future medical research will concentrate on analyzing non-caffeine compounds in coffee to isolate specific therapeutic molecular targets.
“The next step in our research is to identify the specific compounds in coffee that are responsible for these liver-protective associations,” said Shelly Lu, MD, the Women’s Guild Chair in Gastroenterology and director of the Karsh Division of Gastroenterology and Hepatology at Cedars-Sinai.
“Our findings point to biological pathways involving inflammation and scarring and highlight molecular targets that future research can explore to better understand how coffee may influence liver health and who stands to benefit the most.”
